Not a great 4th quarter, down 10% in USD terms yoy, with international being down 15%, but it does complete the picture as regards AUD full year sales.
This now generates AUD FY16 sales of 205.3 v FY15 sales of 192.5, being a 7% increase. Not a bad result given the TST hangover and overall low growth global scenario.
This should result in EPS in the region of 9c and bode well for a dividend in the 6-8 cent range, which should support the current valuation and also excludes any non Axiron revenue, which is not insignificant.
a 6c divvy on 85c is still a net dividend of 7.1% derived on USD sales. Not to be sniffed at.
[using qty average exchange rates which are only a proxy for the actual company translation policy]
FY16 AUD Revenue +7%
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.02M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15873 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 4250 | 1 |
View Market Depth
| Last trade - 07.01am 17/05/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable